Clinical Trial Update: Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine

View source ↗

Summary

This document reports on a descriptive, post-marketing safety study of the Menactra meningococcal conjugate vaccine, conducted by Sanofi Pasteur. The trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Disease | Status: COMPLETED | Results posted: 2014-11-11